SINAPSE SANON Meeting
| When |
Sep 12, 2013
from 12:00 PM to 04:00 PM |
|---|---|
| Where | Glasgow Digital Design Studio |
| Contact Name | Maureen Beaumont |
| Add event to calendar |
 vCal iCal
|
These meetings bring together researchers in imaging, radiotherapy and clinical oncology from around Scotland and the focus is defined by unmet clinical needs such as:
* what is the best way to use imaging to grade glioma?
* how can we distinguish progression from pseudo-progression in patients with glioma?
* which novel PET tracers would best meet the needs of researchers around Scotland?
* can imaging help to explain why some patients deteriorate while their tumour is apparently stable?
* can improvements be made in the use of imaging in radiotherapy planning?
We shall have to restrict attendance to 30 maximum. There is no charge for this meeting and if you would like to register please email maureen.beaumont@glasgow.ac.uk PLEASE NOTE: The first 30 will be accepted, but we would be very grateful if you would only register if you can ENSURE YOUR ATTENDANCE, as failure to turn up would take away a valuable slot from others wishing to attend.
Agenda
|
Time |
Title |
Speaker |
|
13.00 |
Welcome and introduction |
Dave Wyper |
|
|
Brief update on projects arising from previous meetings |
Anthony Chalmers |
|
13.20 |
Clinical trials of PARP inhibitors in glioblastoma: Scientific rationale and clinical experience |
Anthony Chalmers |
|
13.40 |
Keynote Speaker Imaging effects of PARP inhibition in glioblastoma. |
Alan Jackson |
|
14.25 |
Discussion |
|
|
14.40 |
Coffee |
|
|
15.00 |
Optimising imaging data management for research |
John McLean |
|
15.20 |
Developing a radiolabelled PARP inhibitor |
Filip Zmuda |
|
15.50 |
Round Table Discussion Clinical applications of a radiolabelled PARP inhibitor |
Chair: Dave Wyper Alan Jackson Sally Pimlott Anthony Chalmers |
|
16.30 |
Close |
|
